Clinical Trial Update: Thalidomide Maintenance Treatment in DLBCL [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating maintenance thalidomide in diffuse large B-cell lymphoma (DLBCL) is ongoing, with sponsor Nanfang Hospital and Southern Medica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Thalomid (thalidomide)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Lymphoma, Large B-Cell, Diffuse | Phase 3 | Status: UNKNOWN